Cardiovascular disease (CVD) is the most common cause of death in women. Early identification of CVD risk factors in women is ...
Background The optimal revascularisation strategy for patients undergoing percutaneous coronary intervention (PCI) after ...
Background Catheter-directed thrombolysis (CDT) has emerged as a reperfusion strategy for intermediate-risk and high-risk pulmonary embolism (PE), potentially improving thrombus resolution while ...
Background Evidence supporting dietary interventions for heart failure (HF) prevention remains limited. The Dietary ...
Background Quality of life (QoL) measures are commonly used in randomised trials assessing therapies for stable angina. As ...
Background Racial and ethnic differences in diabetic cardiomyopathy (DbCM) exist, with black and Hispanic participants showing poorer health status. It remains unclear whether these differences affect ...
Background Tricuspid regurgitation (TR) is a progressive and underdiagnosed condition associated with poor prognosis. Although the TRI-SCORE is a validated risk model for patients undergoing tricuspid ...
Original research: Operational performance of the 2023 World Heart Federation screening criteria for rheumatic heart disease in a high-risk, resource-limited population (8 July, 2026) ...
Background Secondary prevention is critical for patients with established atherosclerotic cardiovascular diseases (ASCVD). The SMART2 model predicts recurrent ASCVD risk but does not account for ...
Background Guidelines permit up to 360 J for synchronised biphasic electrical cardioversion (ECV) in atrial fibrillation (AF) lasting >48 hours. The CHESS randomised trial reported higher first-shock ...
Introduction Takotsubo cardiomyopathy (TC) is a stress-induced catecholamine acute myocardial dysfunction in the absence of significant coronary disease. The pathophysiology of TC remains poorly ...
Introduction Resistant hypertension remains a clinical challenge, often linked to elevated aldosterone levels not fully controlled by mineralocorticoid receptor antagonists. Aldosterone synthase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results